This inventor holds 14 USPTO granted patents, plus 1 CIPO patent. Top assignees: Monsanto Company, Washington University. Active years: 1988-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Olivette, MO (US) (1988 - 1992)
- St. Louis, MO (US) (1989 - 2001)
Company Filing History:
Years Active: 1988-2001
Title: The Innovations of Gwen G. Krivi: A Pioneer in Protein Production
Introduction: Gwen G. Krivi, an accomplished inventor based in St. Louis, MO, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 14 patents, her work primarily focuses on the innovative production of proteins in prokaryotic systems, which has implications for agricultural and medical applications.
Latest Patents: Among her latest inventions, one notable patent addresses the production of proteins in procaryotes. This method allows for the preparation of polypeptides in bacteria that feature an alanine instead of a methionine at the N-terminus. This breakthrough enables the expression of polypeptides with amino acid sequences similar to naturally occurring eukaryotic proteins, including various bovine and porcine somatotropin species. Another significant invention relates to bovine placental lactogen, which encompasses the amino acid sequences, DNA sequences for production, and its synthetic methods. This innovation is designed to induce biological responses in cattle, thereby enhancing agricultural efficiency.
Career Highlights: Gwen G. Krivi has had a distinguished career, working with notable organizations such as Monsanto Company and Washington University. Her expertise in protein synthesis and genetic engineering has positioned her as a leader in her industry, contributing valuable research and insights that have advanced the biotechnological field.
Collaborations: Throughout her career, Gwen has collaborated with esteemed colleagues, including Ned R. Siegel and Brent R. Larsen. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas and the development of groundbreaking technologies in protein production.
Conclusion: Gwen G. Krivi's contributions to biotechnology through her extensive patent portfolio and collaborative efforts demonstrate her commitment to advancing the field. Her innovations not only enhance our understanding of protein synthesis but also pave the way for future research and applications in agriculture and medicine. With 14 patents to her name, she continues to inspire the next generation of inventors and scientists.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
